Tango Therapeutics (TNGX) Competitors $1.38 +0.04 (+2.61%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$1.32 -0.05 (-4.00%) As of 04/15/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNGX vs. RCKT, ANAB, COGT, LENZ, OPT, BCAX, IMNM, VALN, MRVI, and DNTHShould you be buying Tango Therapeutics stock or one of its competitors? The main competitors of Tango Therapeutics include Rocket Pharmaceuticals (RCKT), AnaptysBio (ANAB), Cogent Biosciences (COGT), LENZ Therapeutics (LENZ), Opthea (OPT), Bicara Therapeutics (BCAX), Immunome (IMNM), Valneva (VALN), Maravai LifeSciences (MRVI), and Dianthus Therapeutics (DNTH). These companies are all part of the "pharmaceutical products" industry. Tango Therapeutics vs. Rocket Pharmaceuticals AnaptysBio Cogent Biosciences LENZ Therapeutics Opthea Bicara Therapeutics Immunome Valneva Maravai LifeSciences Dianthus Therapeutics Tango Therapeutics (NASDAQ:TNGX) and Rocket Pharmaceuticals (NASDAQ:RCKT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends. Which has more risk & volatility, TNGX or RCKT? Tango Therapeutics has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. Comparatively, Rocket Pharmaceuticals has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500. Do analysts recommend TNGX or RCKT? Tango Therapeutics currently has a consensus target price of $12.33, suggesting a potential upside of 796.97%. Rocket Pharmaceuticals has a consensus target price of $43.00, suggesting a potential upside of 558.50%. Given Tango Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Tango Therapeutics is more favorable than Rocket Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tango Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Rocket Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92 Do insiders and institutionals have more ownership in TNGX or RCKT? 79.0% of Tango Therapeutics shares are held by institutional investors. Comparatively, 98.4% of Rocket Pharmaceuticals shares are held by institutional investors. 6.3% of Tango Therapeutics shares are held by insiders. Comparatively, 28.5% of Rocket Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer TNGX or RCKT? In the previous week, Rocket Pharmaceuticals had 16 more articles in the media than Tango Therapeutics. MarketBeat recorded 21 mentions for Rocket Pharmaceuticals and 5 mentions for Tango Therapeutics. Rocket Pharmaceuticals' average media sentiment score of 1.10 beat Tango Therapeutics' score of 0.58 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tango Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rocket Pharmaceuticals 9 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, TNGX or RCKT? Tango Therapeutics has higher revenue and earnings than Rocket Pharmaceuticals. Rocket Pharmaceuticals is trading at a lower price-to-earnings ratio than Tango Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTango Therapeutics$42.07M3.53-$101.74M-$1.21-1.14Rocket PharmaceuticalsN/AN/A-$245.60M-$2.73-2.39 Is TNGX or RCKT more profitable? Rocket Pharmaceuticals has a net margin of 0.00% compared to Tango Therapeutics' net margin of -284.42%. Tango Therapeutics' return on equity of -49.64% beat Rocket Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Tango Therapeutics-284.42% -49.64% -32.00% Rocket Pharmaceuticals N/A -62.62%-54.17% Does the MarketBeat Community believe in TNGX or RCKT? Rocket Pharmaceuticals received 368 more outperform votes than Tango Therapeutics when rated by MarketBeat users. However, 74.36% of users gave Tango Therapeutics an outperform vote while only 73.38% of users gave Rocket Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTango TherapeuticsOutperform Votes2974.36% Underperform Votes1025.64% Rocket PharmaceuticalsOutperform Votes39773.38% Underperform Votes14426.62% SummaryTango Therapeutics beats Rocket Pharmaceuticals on 10 of the 17 factors compared between the two stocks. Remove Ads Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNGX vs. The Competition Export to ExcelMetricTango TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$148.65M$6.32B$5.33B$7.57BDividend YieldN/A3.23%5.11%4.33%P/E Ratio-1.176.7921.7317.81Price / Sales3.53225.93379.1494.58Price / CashN/A65.6738.1534.64Price / Book0.555.866.464.00Net Income-$101.74M$141.86M$3.20B$247.23M7 Day Performance13.64%8.98%6.54%7.26%1 Month Performance-29.49%-12.65%-8.55%-6.26%1 Year Performance-81.22%-11.99%10.33%-0.18% Tango Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNGXTango Therapeutics1.9221 of 5 stars$1.38+2.6%$12.33+797.0%-81.2%$148.65M$42.07M-1.1790Analyst ForecastAnalyst RevisionNews CoverageGap DownRCKTRocket Pharmaceuticals4.6217 of 5 stars$5.19+1.4%$43.00+728.5%-72.8%$545.95MN/A-1.89240Insider TradeNews CoverageGap UpHigh Trading VolumeANABAnaptysBio2.5464 of 5 stars$17.78-3.9%$35.11+97.5%-14.9%$545.26M$91.28M-2.92100Positive NewsCOGTCogent Biosciences2.0881 of 5 stars$4.58-4.0%$14.43+215.0%-25.1%$543.06MN/A-1.8580News CoverageGap DownHigh Trading VolumeLENZLENZ Therapeutics1.7663 of 5 stars$19.50-7.9%$41.67+113.7%+16.9%$537.09MN/A-4.09110Analyst ForecastNews CoverageGap UpHigh Trading VolumeOPTOpthea0.753 of 5 stars$3.41+7.2%$1.33-60.9%-4.2%$524.84M$87,666.000.008Gap UpBCAXBicara TherapeuticsN/A$9.51-10.0%$36.50+283.8%N/A$518.51MN/A0.0032Gap DownIMNMImmunome2.3721 of 5 stars$5.88-0.8%$25.14+327.6%-60.7%$511.27M$9.04M-0.7340VALNValneva1.7395 of 5 stars$6.24+4.3%$16.00+156.4%-17.1%$507.07M$169.58M-48.00700Analyst ForecastMRVIMaravai LifeSciences4.3636 of 5 stars$1.99+2.6%$7.31+267.1%-78.7%$506.13M$259.19M-1.21610DNTHDianthus Therapeutics2.1885 of 5 stars$15.61-3.2%$54.33+248.1%-24.0%$501.47M$6.24M-6.2480Positive News Remove Ads Related Companies and Tools Related Companies RCKT Competitors ANAB Competitors COGT Competitors LENZ Competitors OPT Competitors BCAX Competitors IMNM Competitors VALN Competitors MRVI Competitors DNTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNGX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNGX Stock Free TNGX Stock Alerts